Compare Cytokinetics Inc (CYTK) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Standard Lithium Ltd — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Cytokinetics Inc is far larger — about 17.6× Standard Lithium Ltd's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| CYTK | SLI | |
|---|---|---|
Market Cap | $10.63B | $604.50M |
Sector | Technology | Basic Materials |
52-Week High | $87.26 | $5.65 |
52-Week Low | $34.31 | $1.93 |
Enterprise Value | $10.74B | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
